BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 28256549)

  • 1. Circulating TNF Receptors 1 and 2 Predict Mortality in Patients with End-stage Renal Disease Undergoing Dialysis.
    Gohda T; Maruyama S; Kamei N; Yamaguchi S; Shibata T; Murakoshi M; Horikoshi S; Tomino Y; Ohsawa I; Gotoh H; Nojiri S; Suzuki Y
    Sci Rep; 2017 Mar; 7():43520. PubMed ID: 28256549
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High levels of circulating TNFR1 increase the risk of all-cause mortality and progression of renal disease in type 2 diabetic nephropathy.
    Fernández-Juárez G; Villacorta Perez J; Luño Fernández JL; Martinez-Martinez E; Cachofeiro V; Barrio Lucia V; Tato Ribera AM; Mendez Abreu A; Cordon A; Oliva Dominguez JA; Praga Terente M
    Nephrology (Carlton); 2017 May; 22(5):354-360. PubMed ID: 27003829
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association between circulating tumor necrosis factor receptors and oral bacterium in patients receiving hemodialysis: a cross-sectional study.
    Mikami R; Mizutani K; Gohda T; Gotoh H; Matsuyama Y; Aoyama N; Matsuura T; Kido D; Takeda K; Izumi Y; Fujiwara T; Iwata T
    Clin Exp Nephrol; 2021 Jan; 25(1):58-65. PubMed ID: 32816134
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Circulating TNF receptors 1 and 2 predict stage 3 CKD in type 1 diabetes.
    Gohda T; Niewczas MA; Ficociello LH; Walker WH; Skupien J; Rosetti F; Cullere X; Johnson AC; Crabtree G; Smiles AM; Mayadas TN; Warram JH; Krolewski AS
    J Am Soc Nephrol; 2012 Mar; 23(3):516-24. PubMed ID: 22266664
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Circulating Tumor Necrosis Factor α Receptors Predict the Outcomes of Human IgA Nephropathy: A Prospective Cohort Study.
    Oh YJ; An JN; Kim CT; Yang SH; Lee H; Kim DK; Joo KW; Paik JH; Kang SW; Park JT; Lim CS; Kim YS; Lee JP
    PLoS One; 2015; 10(7):e0132826. PubMed ID: 26177311
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Circulating TNF receptors 1 and 2 predict ESRD in type 2 diabetes.
    Niewczas MA; Gohda T; Skupien J; Smiles AM; Walker WH; Rosetti F; Cullere X; Eckfeldt JH; Doria A; Mayadas TN; Warram JH; Krolewski AS
    J Am Soc Nephrol; 2012 Mar; 23(3):507-15. PubMed ID: 22266663
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Elevation of circulating TNF receptors 1 and 2 increases the risk of end-stage renal disease in American Indians with type 2 diabetes.
    Pavkov ME; Nelson RG; Knowler WC; Cheng Y; Krolewski AS; Niewczas MA
    Kidney Int; 2015 Apr; 87(4):812-9. PubMed ID: 25272234
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 10-Year Associations Between Tumor Necrosis Factor Receptors 1 and 2 and Cardiovascular Events in Patients With Stable Coronary Heart Disease: A CLARICOR (Effect of Clarithromycin on Mortality and Morbidity in Patients With Ischemic Heart Disease) Trial Substudy.
    Carlsson AC; Ruge T; Kjøller E; Hilden J; Kolmos HJ; Sajadieh A; Kastrup J; Jensen GB; Larsson A; Nowak C; Jakobsen JC; Winkel P; Gluud C; Ärnlöv J
    J Am Heart Assoc; 2018 Apr; 7(9):. PubMed ID: 29686027
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association between circulating tumor necrosis factor-related biomarkers and estimated glomerular filtration rate in type 2 diabetes.
    Kamei N; Yamashita M; Nishizaki Y; Yanagisawa N; Nojiri S; Tanaka K; Yamashita Y; Shibata T; Murakoshi M; Suzuki Y; Gohda T
    Sci Rep; 2018 Oct; 8(1):15302. PubMed ID: 30333553
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Circulating TNF receptors 1 and 2 are associated with the severity of renal interstitial fibrosis in IgA nephropathy.
    Sonoda Y; Gohda T; Suzuki Y; Omote K; Ishizaka M; Matsuoka J; Tomino Y
    PLoS One; 2015; 10(4):e0122212. PubMed ID: 25860248
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of metabolic disturbances and malnutrition-inflammation on 6-year mortality in Japanese patients undergoing hemodialysis.
    Nakagawa N; Matsuki M; Yao N; Hirayama T; Ishida H; Kikuchi K; Hasebe N
    Ther Apher Dial; 2015 Feb; 19(1):30-9. PubMed ID: 25196142
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk of ESRD and all cause mortality in type 2 diabetes according to circulating levels of FGF-23 and TNFR1.
    Lee JE; Gohda T; Walker WH; Skupien J; Smiles AM; Holak RR; Jeong J; McDonnell KP; Krolewski AS; Niewczas MA
    PLoS One; 2013; 8(3):e58007. PubMed ID: 23526964
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of tonsillectomy with steroid pulse therapy on circulating tumor necrosis factor receptors 1 and 2 in IgA nephropathy.
    Murakoshi M; Gohda T; Sonoda Y; Suzuki H; Tomino Y; Horikoshi S; Suzuki Y
    Clin Exp Nephrol; 2017 Dec; 21(6):1068-1074. PubMed ID: 28389814
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of serum concentration of TNFR1 with all-cause mortality in patients with type 2 diabetes and chronic kidney disease: follow-up of the SURDIAGENE Cohort.
    Saulnier PJ; Gand E; Ragot S; Ducrocq G; Halimi JM; Hulin-Delmotte C; Llaty P; Montaigne D; Rigalleau V; Roussel R; Velho G; Sosner P; Zaoui P; Hadjadj S;
    Diabetes Care; 2014 May; 37(5):1425-31. PubMed ID: 24623026
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biomarkers of Cardiovascular Disease and Mortality Risk in Patients with Advanced CKD.
    Sun J; Axelsson J; Machowska A; Heimbürger O; Bárány P; Lindholm B; Lindström K; Stenvinkel P; Qureshi AR
    Clin J Am Soc Nephrol; 2016 Jul; 11(7):1163-1172. PubMed ID: 27281698
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumor Necrosis Factor Receptor 1 and 2 Are Associated With Risk of Intracerebral Hemorrhage.
    Svensson EH; Söderholm M; Abul-Kasim K; Engström G
    Stroke; 2017 Oct; 48(10):2710-2715. PubMed ID: 28830973
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Circulating levels of tumor necrosis factor receptors are highly predictive of mortality in patients with rheumatoid arthritis.
    Mattey DL; Glossop JR; Nixon NB; Dawes PT
    Arthritis Rheum; 2007 Dec; 56(12):3940-8. PubMed ID: 18050238
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fractional excretion of tumor necrosis factor receptor 1 and 2 in patients with type 2 diabetes and normal renal function.
    Gohda T; Kamei N; Kubota M; Tanaka K; Yamashita Y; Sakuma H; Kishida C; Adachi E; Koshida T; Murakoshi M; Hagiwara S; Funabiki K; Ueda S; Suzuki Y
    J Diabetes Investig; 2021 Mar; 12(3):382-389. PubMed ID: 32643269
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TNFR1 is associated with short-term mortality in patients with diabetes and acute dyspnea seeking care at the emergency department.
    Wändell P; Carlsson AC; Larsson A; Melander O; Wessman T; Ärnlöv J; Ruge T
    Acta Diabetol; 2020 Oct; 57(10):1145-1150. PubMed ID: 32281000
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Soluble tumor necrosis factor receptor 1 and 2 predict outcomes in advanced chronic kidney disease: a prospective cohort study.
    Neirynck N; Glorieux G; Schepers E; Verbeke F; Vanholder R
    PLoS One; 2015; 10(3):e0122073. PubMed ID: 25823004
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.